Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
BiomX Inc. (PHGE) had Cash Flow from Financial Activities of $2.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-19.14M |
|
-- |
|
-- |
|
$1.30M |
|
$-1.30M |
|
$-17.84M |
|
$-19.14M |
|
$-19.14M |
|
$-19.14M |
|
$-19.14M |
|
$-19.14M |
|
$-19.14M |
|
$-1.30M |
|
$-1.30M |
|
2.60M |
|
2.60M |
|
$-7.38 |
|
$-7.38 |
|
| Balance Sheet Financials | |
$3.04M |
|
-- |
|
$0.21M |
|
$3.25M |
|
$2.45M |
|
-- |
|
$1.69M |
|
$4.13M |
|
$-19.50M |
|
$-0.88M |
|
$-0.88M |
|
6.54M |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
$-1.00M |
|
|
Cash Flow from Financial Activities |
$2.62M |
$4.96M |
|
$1.17M |
|
$-3.79M |
|
$-1.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.16% |
|
2172.53% |
|
-588.74% |
|
2172.53% |
|
$-0.13 |
|
$-2.08 |
|
$-2.08 |
|